BTMS is looking to expand its market share by evolving into a solutions-based company from being a mere equipment manufacturer. Its technological developments have been widely accepted, encouraging it to adopt an aggressive approach by creating a hybrid support infrastructure - health care sales professionals (HCSP) - to accelerate product awareness and acceptance.
"The Demolizer II system is uniquely designed to provide the optimal biomedical waste management solution in a wide variety of settings such as patient care, veterinary care, public venues, and other applications," notes Ms. Tiku. "With systems in every facet of the medical arena as well as nursing homes, sports stadiums, military bases, emergency response, and hospitality services, BMTS has identified over a million potential customers that could benefit from the Demolizer II in the U.S. alone."
Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in new products and technologies within its industry. The recipient company has shown innovation by launching and developing a broad line of emerging products and technologies.
About BioMedical Technology Solutions Holdings, Inc.
BioMedical Technology Solutions Holdings, Inc. trades on the OTCBB under the symbol (BMTL) and is located in Englewood, Colorado sells the Demolizer(R) II through its wholly owned subsidiary BioMedical Technology Solutions, Inc. BMTS' patented Demolizer(R) Technology converts infectious biomedical waste into non-infectious material. BMTS' products provide biomedical waste treatment solutions for the over 1,000,000 low to medium volume medical waste generators in the U.S. and a gl
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved